Literature DB >> 82759

Extrapyramidal side-effects of metoclopramide.

M Kataria, M Traub, C D Marsden.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 82759     DOI: 10.1016/s0140-6736(78)92126-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  The effect of metoclopramide and haloperidol on tardive dyskinesia [proceedings].

Authors:  D N Bateman; D K Dutta; H A McClelland; M D Rawlins
Journal:  Br J Pharmacol       Date:  1979-07       Impact factor: 8.739

2.  Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa.

Authors:  R J Hardie; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

3.  Metoclopramide and tardive dyskinesia in the elderly.

Authors:  M L Orme; R C Tallis
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-18

4.  Cimetidine induced postural and action tremor.

Authors:  D N Bateman; P Bevan; B P Longley; F Mastaglia; I Wandless
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-01       Impact factor: 10.154

5.  Tardive dyskinesia associated with metoclopramide.

Authors:  B E Wiholm; O Mortimer; G Boethius; J E Häggström
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-18

6.  Adverse neurologic effects of metoclopramide.

Authors:  J D Grimes; M N Hassan; D N Preston
Journal:  Can Med Assoc J       Date:  1982-01-01       Impact factor: 8.262

7.  Remoxipride, a selective dopamine D2 receptor antagonist, in tardive dyskinesia.

Authors:  U Andersson; J E Häggström; M I Nilsson; E Widerlöv
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

8.  Metoclopramide: antipsychotic efficacy of a drug lacking potency in receptor models.

Authors:  M Stanley; A Lautin; J Rotrosen; S Gershon; D Kleinberg
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

Review 9.  Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-11       Impact factor: 9.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.